Skip to main content
. 2022 Nov 28;16(11):e0010882. doi: 10.1371/journal.pntd.0010882

Fig 6.

Fig 6

A Anti-GP and B anti-NP antibody levels in LF survivors with and without LASV-specific CD8+T cell responses on 10-day proliferation assay.